These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
764 related articles for article (PubMed ID: 27619676)
21. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823 [TBL] [Abstract][Full Text] [Related]
22. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602 [TBL] [Abstract][Full Text] [Related]
23. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514 [TBL] [Abstract][Full Text] [Related]
24. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma. Qin Y; Zhang Y; Tang Q; Jin L; Chen Y Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer. Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407 [TBL] [Abstract][Full Text] [Related]
26. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737 [TBL] [Abstract][Full Text] [Related]
27. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2. Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870 [TBL] [Abstract][Full Text] [Related]
28. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway. Li X; Zeng X Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643 [TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360 [TBL] [Abstract][Full Text] [Related]
30. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231 [TBL] [Abstract][Full Text] [Related]
31. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression]. Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136 [No Abstract] [Full Text] [Related]
32. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma. Zong M; Liu Y; Zhang K; J Y; Chen L Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391 [TBL] [Abstract][Full Text] [Related]
33. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms]. Zhu ZQ; Hu HF; Zheng XY; Wang F Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454 [No Abstract] [Full Text] [Related]
34. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F. Yang H; Wei YN; Zhou J; Hao TT; Liu XL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965 [TBL] [Abstract][Full Text] [Related]
35. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143 [TBL] [Abstract][Full Text] [Related]
36. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. He Z; Yi J; Jin L; Pan B; Chen L; Song H Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958 [TBL] [Abstract][Full Text] [Related]
38. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
39. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process. Wang H; Shi X; Wu S Mol Cell Biochem; 2020 Sep; 472(1-2):115-123. PubMed ID: 32567032 [TBL] [Abstract][Full Text] [Related]
40. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]